XML 80 R63.htm IDEA: XBRL DOCUMENT v3.23.1
FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Dec. 31, 2022
Financial Instruments  
Schedule of financial assets
             
   December 31, 
   2021   2022   2022 
   CNY   CNY   US$ 
             
Debt instruments at amortized cost:               
Trade receivables: current   41,526    46,760    6,779 
Trade receivables: non-current   9,501    10,520    1,525 
Financial assets included in other receivables   85,224    82,406    11,946 
Financial assets at fair value through other comprehensive income：               
Bills receivable   —      8,500    1,232 
                
Total   136,251    148,186    21,482 
                
Total current   126,750    137,666    19,957 
Total non-current   9,501    10,520    1,525 

 
Schedule of financial liabilities
                
   December 31,   December 31,   December 31, 
   2021   2022   2022 
    CNY    CNY    US$ 
                
Derivatives not designated as hedging instruments：               
Derivative financial liabilities (i)   1,710    824    119 
Financial liabilities at amortized cost:               
Trade payables   21,118    20,326    2,946 
Financial liabilities in other payables and accruals   5,903    6,749    978 
Dividends payable   5,048    —      —   
Lease liabilities   2,189    2,915    422 
Due to related companies   5,710    3,408    494 
Due to the Shareholder   14,050    7,153    1,037 
Interest-bearing loans and borrowings   77,000    74,000    10,729 
                
Total   132,728    115,375    16,725 
                
Total current   57,520    42,777    6,200 
Total non-current   75,208    72,598    10,525 

 

(i)On January 20, 2021, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company issued and sold on January 22, 2021, (i) in a registered direct offering, an aggregate of 3,960,000 of its common shares at a price of US$1.85 per share, and (ii) in a concurrent private placement, warrants initially exercisable for the purchase of an aggregate of 1,584,000 of its common shares with an initial exercise price of US$2.35 per share.
Schedule of the carrying amounts and fair values of the Group’s financial instruments other than those with carrying amounts
                         
   December 31, 
   2021   2022   2022 
   CNY   CNY   US$ 
  

Carrying

amount

  

Fair

value

  

Carrying

amount

  

Fair

value

  

Carrying

amount

  

Fair

value

 
                         
Financial liabilities                              
Interest-bearing loans and borrowings   77,000    79,003    74,000    77,636    10,728    11,255 
Schedule of the fair value measurement hierarchy of the Group’s financial assets and financial liabilities
                  
As of December 31, 2021  Fair value measurement using
  

Quoted prices in active markets

(Level 1)

 

Significant observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

   Total 
   CNY  CNY   CNY   CNY 
Recurring fair value measurement:                  
Financial liabilities                  
Derivative financial liabilities  —     1,710    —      1,710 

 

 

 

As of December 31, 2022  Fair value measurement using 
  

Quoted prices in active markets

(Level 1)

  

Significant observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

   Total 
   CNY   CNY   CNY   CNY 
Recurring fair value measurement:                    
Financial assets                    
Bills receivable   —      8,500    —      8,500 
Financial liabilities                    
Derivative financial liabilities   —      824    —      824 

 

As of December 31, 2022  Fair value measurement using 
  

Quoted prices in active markets

(Level 1)

  

Significant observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

   Total 
   US$   US$   US$   US$ 
Recurring fair value measurement:                    
Financial assets                    
Bills receivable   —      1,232    —      1,232 
Financial liabilities                    
Derivative financial liabilities   —      119    —      119